Caffeine-regulated molecular switches for functional control of CAR T cells in vivo
Sylvander, E.; Salzer, B.; Emminger, D.; Baik, H.; D'Accardio, G.; Schaefer, M.; Mouratidis, K.; Buri, M. C.; Maresch, D.; Urbanetz, A.; Seigner, J.; Marchiori, E.; Munoz-Lopez, A.; Engert, F.; Engels, B.; Mittelstaet, J.; van der Veeken, J.; Rosato, A.; Zuber, J.; Putz, E. M.; Zajc, C. U.; Lehner, M.; Traxlmayr, M. W.
Show abstract
The limited controllability of CAR T cells in patients represents a key challenge of this highly potent immunotherapy. A molecular ON-switch, which can be regulated with a non-toxic and readily available small molecule drug, would represent a major advance towards controllable CAR T therapeutics. For that purpose, we engineered caffeine-responsive heterodimeric ON-switches (CaffSwitches) and demonstrate their high caffeine-dependency and virtually absent leakiness. When incorporating these CaffSwitches into CARs, the resulting CaffCARs were efficiently activated by caffeine concentrations achieved in human plasma after drinking one cup of coffee. Moreover, CaffCAR T cells also showed efficient tumor clearance in an in vivo mouse model, which was completely abolished in the absence of caffeine. This tight control was even observed with c-Jun overexpressing CaffCAR T cells, despite their massive expansion. Together, we anticipate that these novel CaffSwitches will be valuable tools for the development of safe and efficient next generation CAR T cells.
Matching journals
The top 2 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Protease-controlled secretion and display of intercellular signals 97%
- A rational blueprint for the design of chemically-controlled protein switches 96%
- Chemically modified CRISPR-Cas9 enables targeting of individual G-quadruplex and i-motif structures, revealing ligand-dependent transcriptional perturbation. 96%
Similar papers in this journal
- A new universal chimeric-antigen receptor (CAR)- fragment antibody binder (FAB) split system for cancer immunotherapy 96%
- Conditional lethality profiling reveals anticancer mechanisms of action and drug-nutrient interactions 96%
- Simultaneous analysis of pMHC binding and reactivity unveils virus-specific CD8 T cell immunity to a concise epitope set 95%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.